These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19324501)

  • 21. Prize-based contingency management does not increase gambling.
    Petry NM; Kolodner KB; Li R; Peirce JM; Roll JM; Stitzer ML; Hamilton JA
    Drug Alcohol Depend; 2006 Jul; 83(3):269-73. PubMed ID: 16377101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation.
    Shearer J; Metrebian N; Weaver T; Goldsmith K; Strang J; Pilling S; Mitcheson L; Day E; Dunn J; Glasper A; Akhtar S; Bajaria J; Charles V; Desai R; Haque F; Little N; McKechnie H; Mosler F; Mutz J; Poovendran D; Byford S
    Value Health; 2023 May; 26(5):658-665. PubMed ID: 36509367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard magnitude prize reinforcers can be as efficacious as larger magnitude reinforcers in cocaine-dependent methadone patients.
    Petry NM; Alessi SM; Barry D; Carroll KM
    J Consult Clin Psychol; 2015 Jun; 83(3):464-72. PubMed ID: 25198284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of prize-based reinforcement density for simultaneous abstinence from cocaine and heroin.
    Ghitza UE; Epstein DH; Schmittner J; Vahabzadeh M; Lin JL; Preston KL
    J Consult Clin Psychol; 2007 Oct; 75(5):765-74. PubMed ID: 17907858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
    Stitzer ML; Petry NM; Peirce J
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S61-9. PubMed ID: 20307797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinic variation in the cost-effectiveness of contingency management.
    Olmstead TA; Sindelar JL; Petry NM
    Am J Addict; 2007; 16(6):457-60. PubMed ID: 18058410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-cost contingency management in community clinics: delivering incentives partially in group therapy.
    Alessi SM; Hanson T; Wieners M; Petry NM
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):293-300. PubMed ID: 17563216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do noncontingent vouchers increase drug use?
    Schroeder JR; Gupman AE; Epstein DH; Umbricht A; Preston KL
    Exp Clin Psychopharmacol; 2003 Aug; 11(3):195-201. PubMed ID: 12940498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Financing a voucher program for cocaine abusers through community donations in Spain.
    García-Rodríguez O; Secades-Villa R; Higgins ST; Fernández-Hermida JR; Carballo JL
    J Appl Behav Anal; 2008; 41(4):623-8. PubMed ID: 19192866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
    Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
    Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and Effectiveness of Treating Homeless Persons with Cocaine Addiction with Alternative Contingency Management Strategies.
    Mennemeyer ST; Schumacher JE; Milby JB; Wallace D
    J Ment Health Policy Econ; 2017 Mar; 20(1):21-36. PubMed ID: 28418835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.
    Preston KL; Umbricht A; Epstein DH
    Arch Gen Psychiatry; 2000 Apr; 57(4):395-404. PubMed ID: 10768702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals.
    Neufeld K; King V; Peirce J; Kolodner K; Brooner R; Kidorf M
    Drug Alcohol Depend; 2008 Sep; 97(1-2):122-9. PubMed ID: 18486360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
    Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.
    Cunningham C; Stitzer M; Campbell AN; Pavlicova M; Hu MC; Nunes EV
    J Subst Abuse Treat; 2017 Jan; 72():134-139. PubMed ID: 26482136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single- versus dual-drug target: effects in a brief abstinence incentive procedure.
    Correia CJ; Dallery J; Katz EC; Silverman K; Bigelow G; Stitzer ML
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):302-8. PubMed ID: 14599264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.